ArticleAnnals of hematology2026

Durable CNS remission with elranatamab and intrathecal therapy in relapsed/refractory multiple myeloma.

Sinan Mersin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.